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Abstract Dlk, also known as ZIP kinase, is a serine/threonine
kinase that is tightly associated with nuclear structures. Under
certain conditions, which require cytoplasmic localization, Dlk
can induce apoptosis. In search for interaction partners that
might serve as regulators or targets of this kinase we identified
apoptosis antagonizing transcription factor (AATF), a nuclear
phosphoprotein of 523 amino acids. The 1.8 kb mRNA seems to
be ubiquitously expressed. AATF contains an extremely acidic
domain and a putative leucine zipper characteristic of transcrip-
tion factors. Indeed, a Gal4-BD-AATF fusion protein exhibited
strong transactivation activity. Interestingly, AATF interfered
with Dlk-induced apoptosis.
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1. Introduction
Phosphorylation of proteins is a regulatory tool perhaps
most commonly used in eukaryotic cells. The number of pro-
tein kinases that are recognized as members of signal trans-
duction cascades or as key regulators of processes such as cell
cycle progression, transcription, replication, mitosis, apopto-
sis, metabolic processes, etc. is steadily increasing. We have
recently cloned a novel kinase gene which, due to its homol-
ogy to DAP kinase was named Dlk, for DAP like kinase [1].
Dlk was independently isolated as an interaction partner of
ATF-4 [2], a transcription factor of the ATF/CREB family [3].
The new kinase contains a leucine zipper, that mediates
homo- and hetero-dimerization, therefore, it was named zip-
per interacting protein (ZIP) kinase [2]. Dlk (ZIP kinase) is
tightly associated with speckle like nuclear structures some of
which overlap with PML bodies [4]. These latter structures
have been implicated in transcription and regulation of apop-
tosis (reviewed in [5]). Dlk exhibits autophosphorylation and
phosphorylates histones H3 and H4 as well as myosin light
chain in vitro. Together, these ¢ndings suggested a role of Dlk
in transcription. On the other hand, the homology to DAP
kinase, which is involved in interferon Q-induced cell death [6]
suggested a role in apoptosis. Indeed, under certain conditions
which require cytoplasmic localization and association with
actin ¢laments Dlk can induce apoptosis [2,4,7]. This can be
achieved by interaction with Par-4 (prostate apoptosis re-
sponse gene 4) [8], or by C-terminal truncation [4]. However,
both the function of Dlk in the nucleus and the condition and
mechanism by which it induces apoptosis remain to be eluci-
dated.
Apoptosis plays an important role in morphogenesis, tissue
homeostasis, and protection against pathological agents and
stress conditions. Apoptosis can be induced by extracellular
signals such as Fas ligand, TNFK, interferon, etc. or by intra-
cellular signals arising from DNA damage, hypoxia or oxida-
tive stress, oncogenic activation, and other stress situations.
These signals are either translated into genetic activity, by
inducing or repressing pro- or anti-apoptotic genes, respec-
tively, or they are directly translated into apoptotic activity
resulting in activation of caspases and nucleases, membrane
blebbing, chromatin condensation and fragmentation, etc. (re-
viewed in [9]). The decision over cell survival or death appears
to result from a sensitive balance between antagonistically
acting factors such as Bcl-2 and Bax [10].
In search for interaction partners of Dlk that might func-
tion as upstream regulators or as downstream targets we em-
ployed the yeast two-hybrid system [11] and succeeded in iso-
lating several cDNA clones. Four of these encoded known
proteins, ATF-4, Par-4, tropomyosin K and Rabin3 [7]. One
clone encoded an unknown protein of 73 kDa which is a
nuclear phosphoprotein and exhibits strong transactivation
activity. Interestingly, this protein can antagonize Dlk-in-
duced apoptosis. Therefore, it was named AATF, for apop-
tosis antagonizing transcription factor.
2. Materials and methods
2.1. Cell lines
Rat embryo ¢broblasts line REF52.2 were used for expression stud-
ies. Cells were grown as monolayers in Dulbecco’s minimal essential
medium (Gibco-BRL, Eggenstein, Germany) supplemented with 10%
fetal bovine serum (Biochrome Seromed, Berlin, Germany) and anti-
biotics; insect SF9 (Spodoptera frugiperda) cells were used for the
baculovirus expression system and grown in serum free SF900 me-
dium containing 50Wg/ml gentamicin (Gibco-BRL); Saccharomyces
cerevisiae strain Y190 was employed in the two-hybrid system.
2.2. Expression plasmids
Plasmid pEGFP-C1-Dlk and pKEX-HA-Dlk encoding GFP- or
HA-tagged Dlk fusion proteins or deletion mutants thereof were pre-
viously described [1,4]. The corresponding AATF expression con-
structs pEGFP-C1-AATF and deletion mutants thereof were gener-
ated accordingly. Molecular biological techniques followed standard
protocols [12,13].
2.3. Two-hybrid screening
The HybriZAP version (Stratagene, La Jolla, CA, USA) of the two-
hybrid-system [11,14] has been employed as described [7]. Brie£y, the
coding region of Dlk [1] was fused to the Gal4 DNA binding domain
(BD) to be used as bait, and a cDNA library from SV40-transformed
rat cells was fused to the GAL4 transactivation domain (AD) to be
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screened for interaction partners. Yeast Y190 cells were sequentially
transformed with pBD-GAL4 Dlk and the pAD-GAL4 cDNA library
plasmids, His clones were isolated and further assayed for L-galac-
tosidase activity. Positive clones were con¢rmed by retransformation,
the pAD-GAL4 cDNA plasmids were recovered, ampli¢ed in E. coli
and sequenced using the T7 Sequencing kit (Amersham Pharmacia
Biotech, Freiburg, Germany). Complete sequence analysis was per-
formed on both strands by MWG Biotech (Munich, Germany).
2.4. In vitro translation
For in vitro translation the cDNAs isolated as pAD-GAL4 fusion
gene were PCR-ampli¢ed with primers 5P-CCA AAC CCA AAA
ATG GAG ATC GAA TTC-3Pand 5P-CTA GAG TCG ACC CGG
GCT CGA-3P, thereby providing a start codon 5P of the open reading
frame, and cloned into the SmaI-site of pBluescript SK+. In vitro
translation was performed in a coupled transcription/translation sys-
tem (TNT-T7/T3 Coupled Reticulocyte Translation System, Promega,
Heidelberg, Germany).
2.5. Expression and puri¢cation of His-tagged recombinant proteins
from baculovirus-infected SF9 cells
Recombinant baculoviruses encoding histidine-tagged wild-type or
mutant forms of Dlk or AATF were generated and propagated as
described [15]. Cell extracts were prepared by sequential extraction
with isotonic lysis bu¡er (PLB) and high salt RIPA bu¡er [1]; His-
tagged proteins were puri¢ed by a⁄nity chromatography on Ni-NTA
agarose (Qiagen, Hilden, Germany) essentially as described [1]. For
binding studies, His-Dlk was ¢rst bound to Ni-NTA-agarose, the
beads were washed ¢ve times with IMAC-50 (20 mM Tris-HCl pH
8, 0.5 M NaCl, 10% glycerol, 1 mM PMSF, 5 mM L-ME, containing
50 mM imidazole) and once with PLB, in vitro translated and
[35S]methionine-labeled AATF was added and incubated at 4‡C for
2 h. The beads were further washed, bound proteins were eluted and
analyzed by SDS-PAGE and detected by £uorography.
2.6. Kinase assays
Kinase assays were performed with puri¢ed His-tagged Dlk or
AATF in kinase bu¡er containing 50 mM Tris-HCl, pH 7.5,
100 mM NaCl, 5 mM MnCl2, 1 mM DTT, 1 mM PMSF, and 1 WCi
[32P]QATP or [32P]QGTP (speci¢c activity 3000 Ci/mmol, Amersham
Pharmacia Biotech) in 10 Wl reactions at 37‡C for 30 min [1]. Reac-
tions were stopped by 2USDS-PAGE sample bu¡er containing 10 mM
EDTA and subjected to SDS-PAGE and autoradiography.
2.7. Transfection and immuno£uorescence analyses
REF52.2 cells were plated on coverslips and transfected with 300 ng
of respective expression vectors with Lipofectamine (Gibco BRL) for
2 h. In co-transfections one of the protein partners was expressed as
GFP-fusion protein and the other one as HA-tagged protein. The cells
were incubated for 24 h and inspected directly for GFP £uorescence
or stained with anti-Par-4 [8] or anti-HA antibodies (Roche Diagnos-
tics, Mannheim, Germany) for indirect immuno£uorescence. Brie£y,
cells were washed two times with phosphate bu¡ered saline (PBS),
¢xed with 2% paraformaldehyde in PBS for 15 min, washed again
2 times with PBS and permeabilized with 0.2% Triton X-100 in PBS
for 5 min. Cells were washed again, blocked for 30 min with 5% dry
milk, 0.1% Triton X-100 in PBS and then incubated with monoclonal
anti-HA antibody (1:500) for 1 h and, after washing, with goat anti-
mouse Cy3-conjugated secondary antibody (Dianova, Hamburg, Ger-
many) (1:500) for 30 min. DAPI staining of nuclei was performed
after ¢xation and permeabilization of cells with 1 Wg/ml of 4,6-diami-
dino-2-phenylindole (DAPI) for 15 min and subsequently washed as
described above. The subcellular distribution of expressed proteins or
morphological changes of nuclei were analyzed by £uorescence mi-
croscopy with an Axioplan £uorescence microscope (Zeiss).
3. Results
A two-hybrid screen for Dlk interaction partners revealed
four clones encoding known proteins [7] and one clone repre-
senting an unknown cDNA. Sequence analysis of this cDNA
revealed 1796 bp with a continuous open reading frame of
1692 bp translating into a polypeptide of 564 residues. There
Fig. 1. Nucleotide and amino acid sequences of AATF. The follow-
ing features are indicated: acidic domains 1 and 2, leucine zipper,
NLS 1 and 2.
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were two small stretches showing partial homology to human
zinc ¢nger protein ZNF76 [16] (33 of 44 bp) and neural zinc
¢nger factor 1 (NZF-1 [17]) (82 of 134 bp). The residual
sequence did not exhibit signi¢cant homology to known pro-
teins.
As a matter of principle, the two-hybrid system reveals
cDNAs that are translated in frame with the Gal4-activation
domain. Thus, we assumed that the 5P end of the cDNA
including the initiation codon was missing. Northern blot
analysis with a cDNA probe revealed a single mRNA of
about 1800 bp (not shown) indicating that our cDNA clone
was almost complete. Screening of a V-ZAP cDNA library
revealed several positive plaques with identical inserts of
1800 bp. Sequence analysis revealed a 5P extension of only
9 bp with respect to the two-hybrid cDNA, thereby extending
the open reading frame to the very 5P end, without an initia-
tion codon, however. Rather, there was an in frame methio-
nine codon at nucleotide +133, corresponding to triplet 45
(with respect to the V cDNA clone), which ful¢lled the re-
quirements of an eukaryotic initiation codon. In vitro trans-
lation of the cDNA with and without an arti¢cial initiation
codon at the 5P end (see Section 2) revealed products of 76
and 73 kDa, respectively (not shown) indicating that natu-
rally, initiation occurred indeed at codon 45 of the open read-
ing frame. Accordingly, the protein product consists of 523
residues. We called this protein AATF. The complete amino
acid sequence is shown in Fig. 1. The protein can be roughly
divided into two domains, an N-terminal acidic domain and a
relatively basic domain in the C-terminus. The acidic domain
contains two highly acidic stretches from residues 20^49 and
107^170 which are separated by a Ser/Thr-rich domain. Sec-
ondary structure calculations predict mostly K helical struc-
tures. There is a putative leucine zipper between residues 239
and 260, putative nuclear localization signals (NLS) around
residues 300 and 467, and several putative phosphorylation
sites for protein kinases CKII, PKA and PKC.
To determine the interaction domains of Dlk and AATF a
series of deletion mutants was generated and employed as
Gal4-fusion proteins in the two-hybrid interaction assay.
The Dlk deletion mutants included deletion of the leucine
zipper (vC1), deletion of an Arg-rich domain (vC2) and dele-
tion of the complete extra kinase domain (vC3) (see Fig. 2A).
Likewise, in AATF we sequentially deleted from the carboxy
terminus NLS2, NLS1, and the putative leucine zipper (see
Fig. 2B). Full length AATF exhibited a functional interaction
only with full length Dlk, but not with mutants lacking the
leucine zipper (Fig. 2A). On the other hand, full length Dlk
interacted with full length AATF as well as with deletion
mutants terminating at residue 390 or 279 but not at 179
lacking the putative leucine zipper (Fig. 2B). These results
Fig. 2. Deletion mapping of the interaction domains between Dlk and AATF and test for transactivation using the two-hybrid system. Circles
on the left show segments where yeast cells transfected with the indicated expression constructs were plated. A: Full length Gal4-AD-AATF
was cotransfected with Gal4-BD-Dlk variants; B: Full length Dlk was co-expressed with AATF variants; the segment with pBD-AATF trans-
formed cells demonstrates transactivation activity of AATF. Schemes on the right show the extensions of the deletion mutants used.
Fig. 3. A: In vitro binding of AATF to Dlk. cDNAs encoding full
length or deletion mutants of AATF were translated and labeled
with [35S]methionine in vitro and allowed to bind to His-tagged Dlk
immobilized to Ni-NTA agarose as described under Section 2.
Please note: the doublets 1, 2 and 3, 4 show binding of full length
AATF or deletion mutant AATF390 to Dlk versus control beads,
respectively, while the doublets 5, 6 and 7, 8 show translation prod-
ucts AATF279 and AATF179 prior and after binding to Dlk-Ni-
NTA agarose, respectively (see Fig. 2B for deletion constructs). B:
Phosphorylation of AATF in vitro. His-tagged AATF was expressed
in the baculovirus system, puri¢ed via Ni-NTA agarose and sub-
jected to a kinase reaction in the absence (lanes 1 and 3) or pres-
ence (lane 2) of Dlk and [32P]QATP (lanes 1 and 2) or [32P]QGTP
(lane 3) as phosphate donor.
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suggested that interaction of these proteins occurred via their
leucine zippers.
Complex formation between Dlk and AATF was veri¢ed
by in vitro binding studies. To this end, the cDNA of full
length and truncated forms of AATF were translated in vitro
and tested for binding to His-tagged Dlk that was bound to
Ni-NTA agarose and used as a⁄nity matrix. As shown in Fig.
3A, full length and deletion mutant AATF390 bound specif-
ically to Dlk (lanes 1 and 3) but not to control beads (lanes 2
and 4). Mutant AATF179 did not bind, as expected (lane 8).
The lack of binding of mutant 1^279 (lane 6) (which was
positive in the two-hybrid assay) may be explained by con-
formational restraints that may not be present in the Gal4-
fusion proteins.
To test whether AATF was a substrate of Dlk, His-tagged
AATF was expressed in the baculovirus system, puri¢ed on
Ni-NTA agarose and employed in kinase reactions using pu-
ri¢ed His-tagged Dlk as kinase. Surprisingly, AATF was
phosphorylated to a similar extent whether Dlk was present
or not (Fig. 3B, lanes 1 and 2) suggesting that AATF was
phosphorylated by an associated kinase rather than by Dlk.
Since AATF is a rather acidic protein and contains eight
potential CKII phosphorylation sites we considered that it
was phosphorylated by CKII. Indeed, when the kinase reac-
tion was carried out in the presence of GTP, which is indica-
tive of CKII activity, AATF was phosphorylated to the same
extent as with ATP (Fig. 3B, lane 3).
Expression analyses may reveal hints as to whether a pro-
tein might perform tissue-speci¢c functions. A multiple tissue
mRNA blot containing transcripts from brain, heart, skeletal
muscle, lung, liver, spleen, kidney and testis of adult rat was
hybridized with labeled cDNA probe. This experiment re-
vealed ubiquitous expression of AATF with little quantitative
variation (data not shown). Thus, AATF may perform a gen-
eral function.
The acidic domain and the putative NLS sequences sug-
gested that AATF might act as transcription factor. Expres-
sion as GFP-AATF fusion protein revealed a di¡use distribu-
tion in the nucleus in virtually all of the cells. (not shown).
Only rarely did we observe AATF in speckles as seen for Dlk
[1,4]. Surprisingly, co-expression of AATF with Dlk resulted
in a di¡use distribution of Dlk rather than relocation of
AATF to speckles suggesting that AATF interfered with
speckle association of Dlk.
To test for transcriptional activity, AATF was fused to the
Gal4 DNA binding domain and tested for activation of Gal4
responsive promoters (His and L-galactosidase) in yeast cells.
The His auxotroph yeast strain employed in the two-hybrid
system was transformed with the Gal4-BD-AATF fusion con-
struct and assayed for His autotrophy and L-galactosidase
activity. Indeed, this fusion construct behaved as a potent
transactivator (see Fig. 2B).
We next asked whether AATF would in£uence one of the
known functions of Dlk, induction of apoptosis. As men-
tioned above, Dlk and its interaction partner Par-4 seem to
cooperate in apoptosis. Neither protein can induce apoptosis
on its own. But co-expression of Dlk and Par-4 causes cyto-
plasmic retention of Dlk, association with actin ¢laments, and
e⁄cient induction of apoptosis [7]. However, when Dlk and
Par-4 were co-expressed with AATF, apoptosis was greatly
reduced (Fig. 4). Similarly, when the Dlk mutant vC2, which
due to its cytoplasmic localization is a potent inducer of apop-
tosis [4], was co-expressed with AATF, apoptosis was greatly
inhibited. Thus, AATF seems to antagonize the apoptotic
function of Dlk.
4. Discussion
In search for interaction partners of Dlk we identi¢ed a
novel transcription factor, AATF. The interaction with Dlk
was veri¢ed by in vitro binding and the interaction domains
were mapped to a small region containing the leucine zipper.
Known transcription factors with leucine zippers appear to
act as homo- or hetero-dimers. Thus, AATF might interact
with other transcription factors, too. However, whether
AATF contains a bona ¢de leucine zipper has to be experi-
mentally con¢rmed. One peculiarity of AATF is its highly
acidic domain consisting of two stretches with 50 or even
59% acidic residues. This high degree of acidity is surpassed
only by NZF-1 which has an acidic domain of 85 residues
with 80% Glu or Asp [17]. It is this acidic domain which is
homologous between AATF and NZF-1. Such acidic domains
of transcription factors might participate in chromatin remod-
elling as shown recently for VP16 [18] and BRCA1 [19] and
thereby facilitate transcription. The classi¢cation of AATF as
a transcription factor is so far based on its ability as Gal-4
fusion protein to transactivate Gal-4 responsive promoters.
Several transcription factors such as VP16 [20], p53 [21], or
BRCA-1 [22] have been identi¢ed this way. Clearly, the genes
and their response elements targeted by AATF have to be
elucidated.
Interestingly, all identi¢ed interaction partners of Dlk, in-
cluding AATF, are either transcription factors (ATF4 and
Par-4) and/or modulators of apoptosis (Par-4), suggesting
that Dlk participates in a particular apoptotic pathway, per-
haps through regulating transcription of speci¢c target genes.
On the other hand, Par-4 appears to be a regulator of Dlk as
it causes relocation of Dlk to the cytoplasm and thereby in-
duction of apoptosis [7]. Since AATF was not phosphorylated
by Dlk, at least not in vitro, yet appeared to antagonize Dlk-
mediated apoptosis, it might as well be a regulator rather than
Fig. 4. AATF interferes with Dlk/Par-4-induced apoptosis. REF52
cells were transfected with expression plasmids encoding GFP-Dlk,
GFP-DlkvC2, Par-4, and/or GFP-AATF, as indicated. In co-expres-
sion experiments, GFP- or HA-tagged versions were employed to al-
low discrimination of the respective proteins. After 24 h, 100 GFP-
positive cells were stained as described under Section 2 and scored
for characteristic apoptotic alterations as judged by membrane bleb-
bing, chromatin condensation and nuclear fragmentation. All trans-
fections were performed in triplicate.
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a target of Dlk. It might do so by competing for binding of
pro-apoptotic factors. Alternatively, AATF might act as tran-
scription factor by enhancing expression of anti-apoptotic
genes like bcl-2 or repressing pro-apoptotic genes like bax.
In this case, AATF might be linked to the anti-apoptotic
Akt kinase pathway [23]. Akt inactivates pro-apoptotic tran-
scription factor forkhead [24]. It might as well activate AATF
as an anti-apoptotic transcription factor. Another question is,
whether AATF is speci¢c for Dlk-mediated apoptosis or
whether it acts in a more general way. Investigating these
issues will provide further insights into the complex network
regulating cell death and survival.
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